159 related articles for article (PubMed ID: 35069790)
1. Elevated Serum Fibroblast Growth Factor 21 Is Relevant to Heart Failure Patients with Reduced Ejection Fraction.
Fan L; Gu L; Yao Y; Ma G
Comput Math Methods Med; 2022; 2022():7138776. PubMed ID: 35069790
[TBL] [Abstract][Full Text] [Related]
2. High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction.
Fan L; Gu L; Yao Y; Ma G
Perfusion; 2024 Mar; 39(2):285-293. PubMed ID: 36321746
[TBL] [Abstract][Full Text] [Related]
3. Contribution of serum FGF21 level to the identification of left ventricular systolic dysfunction and cardiac death.
Shen Y; Zhang X; Pan X; Xu Y; Xiong Q; Lu Z; Ma X; Bao Y; Jia W
Cardiovasc Diabetol; 2017 Aug; 16(1):106. PubMed ID: 28821258
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy.
Gu L; Jiang W; Zheng R; Yao Y; Ma G
Cardiology; 2021; 146(1):27-33. PubMed ID: 33264784
[TBL] [Abstract][Full Text] [Related]
5. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
[TBL] [Abstract][Full Text] [Related]
6. Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction.
Chou RH; Huang PH; Hsu CY; Chang CC; Leu HB; Huang CC; Chen JW; Lin SJ
Sci Rep; 2016 Sep; 6():33953. PubMed ID: 27650781
[TBL] [Abstract][Full Text] [Related]
7. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics of heart failure with recovered ejection fraction].
Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682
[No Abstract] [Full Text] [Related]
9. Value of brain natriuretic peptide after acute myocardial infarction.
Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.
Koller L; Kleber ME; Brandenburg VM; Goliasch G; Richter B; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; Berger R; Mörtl D; Hülsmann M; Pacher R; März W; Niessner A
Circ Heart Fail; 2015 Nov; 8(6):1059-67. PubMed ID: 26273098
[TBL] [Abstract][Full Text] [Related]
11. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
12. The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
Kocaman SA; Taçoy G; Ozdemir M; Açıkgöz SK; Cengel A
Anadolu Kardiyol Derg; 2010 Dec; 10(6):519-25. PubMed ID: 20952357
[TBL] [Abstract][Full Text] [Related]
13. Similar predictive value of six-minute walking distance and B-type natriuretic peptide in heart failure with reduced to mid-range ejection fraction.
Scardovi AB; De Maria R; Galeotti GG; Faggiano P; Arcari L; Ghio S; Temporelli PL; Rossi A; Magni G; Simioniuc A; Ricci R; Dini FL
Monaldi Arch Chest Dis; 2019 Jul; 89(2):. PubMed ID: 31315349
[TBL] [Abstract][Full Text] [Related]
14. Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction.
Okamoto Y; Fujita S; Morita H; Kizawa S; Ito T; Sakane K; Sohmiya K; Hoshiga M; Ishizaka N
Heart Vessels; 2016 Jan; 31(1):66-73. PubMed ID: 25223536
[TBL] [Abstract][Full Text] [Related]
15. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes.
Albert J; Lezius S; Störk S; Morbach C; Güder G; Frantz S; Wegscheider K; Ertl G; Angermann CE
J Am Heart Assoc; 2021 Feb; 10(3):e017822. PubMed ID: 33496189
[TBL] [Abstract][Full Text] [Related]
16. Acute systolic heart failure with normal admission BNP: clinical features and outcomes.
Omar HR; Guglin M
Int J Cardiol; 2017 Apr; 232():324-329. PubMed ID: 28094130
[TBL] [Abstract][Full Text] [Related]
17. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
18. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
[TBL] [Abstract][Full Text] [Related]
19. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
[TBL] [Abstract][Full Text] [Related]
20. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
